Teva files petition with U.S. FDA against MS drug competitors
July 03, 2014 at 10:11 AM EDT
TEL AVIV, July 3 (Reuters) - Teva Pharmaceutical Industries has filed a so-called citizen petition with the U.S. Food and Drug Administration (FDA), aiming to delay cheap generic competition to Copaxone, its top-selling treatment for multiple sclerosis (MS).